Your browser doesn't support javascript.
loading
Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations.
Ma, Junpeng; Bai, Han; Gong, Tian; Mao, Weikang; Nie, Yijun; Zhang, Xuan; Da, Yanyan; Wang, Xiaorui; Qin, Hongyu; Zeng, Qiqi; Hu, Fang; Qi, Xin; Shi, Bingyin; Zhang, Chengsheng.
Affiliation
  • Ma J; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University,17 Yongwai Zhengjie,
  • Bai H; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Gong T; Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University,17 Yongwai Zhengjie, Nanchang 330006, China.
  • Mao W; LC-BIO TECHNOLOGIES (HANGZHOU) CO., LTD., Hangzhou 310000, China.
  • Nie Y; Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University,17 Yongwai Zhengjie, Nanchang 330006, China.
  • Zhang X; Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University,17 Yongwai Zhengjie, Nanchang 330006, China.
  • Da Y; Center for Molecular Diagnosis and Precision Medicine, and The Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University,17 Yongwai Zhengjie, Nanchang 330006, China.
  • Wang X; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Qin H; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Zeng Q; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Hu F; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Qi X; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China.
  • Shi B; Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China.
  • Zhang C; Precision medicine center, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an 710061, China; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Building 21, Western China Science and Technology Innovation Harbor, Xi'an 710000, China;
Immunol Lett ; 249: 23-32, 2022 09.
Article in En | MEDLINE | ID: mdl-36055412

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Immunol Lett Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Immunol Lett Year: 2022 Document type: Article Country of publication: